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Abstract 
Opsoclonus-myoclonus syndrome is a rare but serious neurological condition resulting in loss of control 
of eye movements, often accompanied by difficulties in posture and movement control with reports of 
sensory sensitivities potentially impacting on behaviour.  This pilot study characterises the presence of 
atypical sensory behaviours in opsoclonus-myoclonus syndrome through questionnaire survey of a cohort 
of families.  The Short Sensory Profile, Vineland Adaptive Behaviour Scale and Developmental 
Behaviour Checklist were distributed to 30 families; 16 were returned anonymously. Atypical sensory 
behaviours were identified in a large proportion (62.5%). Children reported as being more anxious 
showed greater sensitivity to auditory stimuli (U (14) 11, p = .026). This is consistent with recent 
recognition of more extensive disease neuro-cognitive effects in Opsoclonus-myoclonus syndrome.  
Further research is needed to increase understanding of the complex pathology of this disease and to 
provide indicators for sensory and behavioural as well as pharmacological interventions.   
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Introduction 
Opsoclonus-myoclonus syndrome, also known as ‘dancing eye syndrome’, typically presents in children 
between 12 months and 3 years of age with variable outcome.1-4 Children develop opsoclonus, a rapid, 
involuntary, conjugate, multidirectional, saccadic eye movement disorder; accompanied by myoclonus 
and ataxia. Irritability and sleep disturbance are often also observed; and less frequently neurological 
symptoms like vomiting and mutism may also feature.3,4  Whilst the illness may be monophasic or 
multiphasic; many (over 50%)  children experience learning, behavioural and coordination difficulties 
with problems persisting into adulthood.3,4,6,7 Recent report suggests some improvements in outcomes 
with increased immunosuppression8.   
A neuroblastoma is present in about 50% of children and presumed to be an immune-mediated para-
neoplastic condition whereby immune perturbations have been identified in the form of reactivity of 
patient derived humoral and cellular components to tumour cell lines.5 Central nervous system auto-
reactivity in opsoclonus-myoclonus syndrome may also occur in the absence of tumour, where a post-
infectious aetiology is purported to be the trigger.3,4 Clinical and radiologic evidence now points to extra-
cerebellar involvement in opsoclonus-myoclonus syndrome.9 Electrophysiological studies also appear to 
support the clinical observation that some of the neuro-behavioural sequelae following opsoclonus-
myoclonus syndrome may result from aberrant sensory processing and modulation.10,11   
Sensory modulation dysfunction is defined as the impaired ability of an individual to regulate and 
organise responses to sensations in a graded and adaptive manner and appropriate to situational demands; 
manifesting as  over-responsiveness (reduced sensory threshold); under-responsiveness (high sensory 
threshold); or sensory seeking behaviours which may be representative of an under-responsive sensory 
system.12-13  It has been conceptually and empirically associated with a number of behavioural 
manifestations particularly amongst individuals with neurodevelopmental disorders14-22  Atypical sensory 
processing has been suggested as a major factor reducing participation and engagement in daily activities 
across a number of developmental disorders.12-23  Patient reports, clinical observations of features 
  
 
associated with opsoclonus-myoclonus syndrome and electrophysiological evidence suggest that over-
responsiveness to sensory stimuli may significantly impact on participation in daily activities. 
The relative contribution of sensory over-responsiveness as an independent symptom is however 
confounded with the overlap of symptoms with those of anxiety and the lack of a ‘gold standard’ for the 
identification of sensory modulation dysfunction or sensory processing disorder, with questionnaire report 
most commonly used12,22,23.  The determination of  an abnormal behavioural response (a defined cut 
point) from quantitative analysis of deviations  of what generally constitute a range of typical behaviours, 
may be augmented by biological measures (e.g. electrodermal responses) as developed by Miller and 
colleagues, however the correlation between these and behaviour report are not universal. 12,13  
This background provides a plausible argument for sensory modulation dysfunction and or anxiety 
affecting performance in daily activities for young people opsoclonus-myoclonus syndrome.  The aim of 
this study was to gather preliminary information, via an anonymous questionnaire survey, of the presence 
of sensory processing problems (and/or anxiety) in opsoclonus-myoclonus syndrome and their impacts on 
cognitive, social and adaptive functioning, in order to guide future research.   
 
Methods 
This project was designed as a questionnaire survey of a convenience cohort of families with a young 
person with opsoclonus-myoclonus syndrome.  Ethical approval conforming to the Declaration of 
Helsinki was received from the National Research Ethics Service (2/LO/0115).  
Participants  
Questionnaire packs with information regarding the project were distributed to families with a 
child/young adult with opsoclonus-myoclonus syndrome via the Dancing Eye Syndrome Support Trust, 
with an anonymous code linking the questionnaires within the pack. Stamped self-addressed envelopes 
were provided for return to the research team.  Informed consent was assumed via return of completed 
questionnaires. Sample size was therefore limited to 30 registered families with a return rate of 53% 
  
 
resulting in a sample of 16. Recruitment and enrolment did not distinguish between individuals at 
different disease phases (eg. Acute, on-going treatment or remission).  
 
Measures 
Demographic information was collected alongside questions regarding the age Opsoclonus-Myoclonus 
Syndrome was acquired and reason (if known) alongside any current medical treatments, therapeutic 
procedures received and educational placement.  
The Short Sensory Profile Caregiver Questionnaire24 was completed to establish the profile of 
sensory responses. Sensitivity and specificity have not been published although discriminate validity is 
reported as greater than 95%.  Total scores range from 38 to 190 with cut-off scores defining typical (155-
190) vs probable (140-154) and definitely atypical (38-141) sensory behaviours determined from the 
standardisation of the Short Sensory Profile.24   
The Vineland Adaptive Behaviour  Scale 25, was used as a standardised scale of adaptive behaviour 
and development obtained through parental/key care giver report across four domains of social, 
communication, daily living and motor skills. Questions relate to relevant skill areas and contribute to an 
overall adaptive behaviour score.   Good reliability and validity are reported.25. 
The Developmental Behaviour Checklist 26 a 96 item parent report instrument of childhood 
behavioural disorders was used to measure anxiety.   An anxiety score is derived by summing the 12 
items of the anxiety subscale with high scores reflecting high anxiety (score range 0-24).  Items linked to 
sensory behaviour are limited to two and data can be rerun removing these items.   
 
Data Analysis 
Statistical analyses, using the statistical package SPSS (v.19), were undertaken relevant to the original 
aims.  Missing data were prorated if less than 10% of subscale was missing as an average for the section. 
Descriptive statistics explored the distribution, characteristics and results of the children across 
questionnaires.  Primary outcomes considered the proportion of individuals who are reported to have 
  
 
sensory processing problems.  Secondary outcomes considered the relationship between anxiety and 
adaptive behaviour and participation in daily activities; controlling for additional factors which may 
influence engagement and participation through Spearman correlation analyses and between group 
comparisons of children with and without reported anxiety.  Model assumptions were checked and 
parametric (ANOVA) and non-parametric (Chi2 and Mann Whitney U) analysis methods used as 
reported.  
 
Results 
Sixteen of 30 (53%) questionnaires were returned for 13 females and three males. Mean age was 7 
years 6 months (range 21-168 months) at time of questionnaire completion. Time since diagnosis ranged 
from 6 months to 12.4 years (M 6 years, SD = 4.5).  Eleven children were reported to have had a 
neuroblastoma and two a known viral infection with three not providing information.  At time of study 
nine children were not on medication, one on cyclosphosphamide and three on prednisolone (See Table 1 
and Appendix 1 for participant characteristics). Two returned Vinelands required prorating on one or two 
scales and two were not possible to prorate. 
<Table 1 approximately here> 
There were no significant differences in developmental ability between older or younger children, 
contrasting impact of relatively acute versus chronic stage of opsoclonus-myoclonus, nor between males 
and females (See Table 1).   However, all but one of the older children showed significant delays in 
adaptive behaviour with percentile scores of five or below as opposed to only two of the five younger 
children1.  There were also no differences in age, time since diagnosis, and overall developmental ability 
(as measured on the Vineland) between children reported on the Developmental Behaviour Checklist as 
being anxious or not (t(13) <135, p > .05 across all measures; See Table 2).  
                                               
1 Data were re-analysed without the outlier on the Vineland and differences between younger and older 
children were only evident on overall adaptive behaviour with older children reportedly more delayed for 
their age across domains (p=.053). 
  
 
Younger children (50%) were more likely to be on medication than children over 6 years (20%), at 
questionnaire completion, as they are temporally closer to disease onset. Older children (>6 years; n=8) 
showed poorer overall development as reported on the Vinelands (U (14) 7.5, p =.029).  Older children 
(90%) had also received more therapies such as physiotherapy, speech and language therapy and 
occupational therapy and additional educational support than younger children (30%).  
 There were eight children reported to have atypical sensory behaviours (50%), two probable 
(12.5%) and six (37.5%) considered to be within the typical range according to the criteria of the Sensory 
Profile.  Differences in sensory processing were evident  between children reported as having anxiety and 
those that did not with children with anxiety reported to have hyper-responsiveness to auditory stimuli 
(Auditory: U  11, p =.026, r = .593) which contributed to the differences in the  Short Sensory Profile 
total (U 12.5, p = .038, r = .513). The numbers of children reported as having anxiety were significantly 
higher amongst children who also met criteria for atypical sensory behaviour (χ2 (2) 8.56, p = 0.032)  
with the likelihood ratio reducing (χ2 (2) 5.74,  p = 0.06) with removal of the two children who were 
below the standardisation age (3 years) of the Sensory Profile and Developmental Behaviour Checklist.  
See Table 2 and Figures 1 and 2.    
<Table 2 approximately here> 
<Figure 1 approximately here> 
<Figure 2 approximately here> 
Significant correlations were evident between sensory behaviours and anxiety subscale of 
Developmental Behaviour Checklist (rho= -.724, p = .028), standard scores and percentile scores of the 
Vineland (rho=.761, p = .002, rho = .593, p = .025 respectively) and the anxiety scale of the 
Developmental Behaviour Checklist and both Vineland standard scores and percentiles (rho = -0.708, p = 
.033; rho = -0.681, p=0.043).    In view of two children being outside of the standardisation range on the 
Sensory Profile and Developmental Behaviour Checklist we reanalysed our data without these children 
with similar trends across results. 
  
 
 
Discussion 
This study aimed to gather preliminary information via questionnaire survey of the potential presence of 
sensory processing problems in opsoclonus-myoclonus syndrome and possible impact on cognitive, social 
and adaptive functioning. . Our results suggest that anxiety was associated more specifically with hyper-
sensitivity to auditory stimuli rather than a generalised sensory modulation dysfunction in some, but not 
in all of the children.   
Ben-Sasson and colleagues16, in a meta-analysis of sensory modulation dysfunction, in individuals 
with autism spectrum disorders, showed that presentation of sensory modulation dysfunction is influenced 
by age, severity of autism and type of control group used for comparison, while Lane et al14 found anxiety 
to be influenced by the magnitude of response to sensory stimuli.  Sensory-based phenotypes based on 
specificity of sensory responsiveness in autism have also been suggested.27 These findings suggest  a 
potentially important interaction between anxietyand expression of sensory symptoms.  Schneider and 
colleagues28  have used a primate model to show the influence of prenatal stress (including exposure to 
alcohol and or adverse sounds) on both striatal dopamine levels, evaluated using positron emission 
tomography, and increased withdrawal  to sensory stimuli (aversion to repetitive tactile stimuli and 
reduced habituation to stimuli across trials in 5 to 7 year old rhesus monkeys).  Infant stress 
(neuroinflammation) may therefore be hypothesised to contribute to an attenuation of sensory sensitivity, 
as a protective response in the initial stages but which may later contribute to presentation of negative 
behaviours (e.g. withdrawal from light touch or auditory stimuli).  What is unusual in our data is that this 
negative response appears to be relatively restricted to auditory stimuli.   
We had anticipated that more atypical responses would be evident across sensory systems in line with 
Schneider et al.27 as a systemic response to infant stress. Currently, the selectivity of the hypersensitivity 
to the auditory system in patients in this cohort is surprising as opsoclonus-myoclonus syndrome appears 
to involve oculomotor components including blurred and or double-vision. A recent neuroimaging study 
has however suggested more extensive degeneration with cortical thinning across visual as well as 
  
 
cognitive, language, and motor areas additional to cerebellar involvement of pontine-cerebellar regions.9   
What has not previously been considered is whether there is a direct effect on the inferior colliculus and 
the processing of auditory stimuli.  Autoimmune mechanisms may therefore be more ‘site specific’ in 
opsoclonus-myoclonus syndrome than originally conceptualised.3,4,29.  What is not possible to conjecture 
from our results is the representation of atypical sensory behaviours in opsoclonus-myoclonus syndrome 
based on aetiology as evidenced in developmental and genetic disorders.27,30-32  .  As such, the potential 
selective impact on auditory processing  in opsoclonus-myoclonus syndrome could perhaps be explained 
by the focality of inflammation around inferior colliculi and auditory pathways or the vulnerability of 
auditory processing to a more generic disease effect (cortical or sub-cortical) with consequent 
developmental impact.   
There is as yet no known relationship between hyperacusis and auditory sensitivity across different 
environmental sounds.  The complex pathway of opsoclonus-myoclonus syndrome with some children 
showing rapid spontaneous improvement without treatment and others showing persistent presentation of 
multiple symptoms with unclear links to aetiology  suggests a complex interaction between the infant, 
disease and environment.4   Of note is the potential influence of prednisolone on behaviour.  Analysis of 
the reported behaviours of the three children in our study on prednisolone (ages 1year 9months, 4years 
2months and 8years 9months), showed all to be reported as anxious, but all within normative ranges on 
the Vinelands and only one showing significant sensory behaviours on the Sensory Profile.  Consideration 
of the interaction of medication on symptom expression in opsoclonus-myoclonus syndrome requires 
elucidation through further research. 
While modest, our results suggest a potential role of auditory hypersensitivity in opsoclonus-
myoclonus syndrome which may be integral to the condition and or a secondary consequence in some 
cases, which may exacerbate or represent the persistence of symptoms.  What remains unknown is 
whether sensory modulation dysfunction is evident in other neuroinflammatory diseases which might 
provide potential markers for the disease process. Comparisons with other diagnostic groups that have 
received immunomodulation as well as those with neurodevelopmental disorders with and without 
  
 
sensory processing deficits, may provide insights into this complex disease, neurological sequelae and 
current management.  The important aspect of the current findings is the identification of a risk of sensory 
processing difficulties, particularly of auditory stimuli, linked to anxiety in opsoclonus-myoclonus 
syndrome.   We recommend that parents and clinicians consider the child’s responses to auditory stimuli 
through observation, and report of behaviours across contexts with consideration of appropriate therapies 
to reduce sensory sensitivity.    
 
Limitations 
The use of the Short Sensory Profile to identify sensory processing disorders in children is confounded by 
the limited discrepancy between chronological age and mental age and lack of specificity due to overlay 
with diagnostic criteria within the Sensory Profile . The anonymous distribution of questionnaires in this 
survey did not allow for provision of age specific questionnaires nor exploration of aetiological and early 
medical inventions as factors contributing to outcome.  While variations of the full Sensory Profile exist 
for infants and adolescents, the Short Sensory Profile is only available in one version which may not be 
sensitive to differences in younger and older children – although this limitation is more likely to magnify 
results.  The disproportionate response rate with more females than males is not considered to represent a 
bias of presentation of opsoclonus-myoclonus syndrome in either the acute or chronic phases. However, 
gender differences in the persistence of behaviour symptoms remains an unanswered question and further 
research with a broader population is needed.  While our sample size was small, the recruitment rate was 
none the less high for this type of study (53%). This raises the question as to whether families may have 
been invested in the concept of sensory processing difficulties in opsoclonus-myoclonus syndrome.  The 
study could also have been improved with the use of a sibling control group, however this would have 
increased the burden to respondent families. 
 
Conclusion 
  
 
The atypical responses to sensory processing in a large proportion of our modest sample support the need 
for further research in this area to: a) increase understanding of the complex pathology and 
developmental, psychological and sensory functioning of opsoclonus-myoclonus syndrome and their 
interactions and b) provide indicators for behavioural as well as pharmacological interventions.  Findings 
will provide invaluable markers regarding the need and nature of more structured and sophisticated 
projects.   
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Figure legend 
 
Figure 1 Short Sensory Profile domain scores of children  with and without anxiety as reported on the 
Developmental Behavior Checklist 
 
Figure 2 Numbers of children meeting criteria for sensory processing disorder with or without anxiety 
 
  
  
 
 
Table 1. Participant characteristics by younger and older age groups 
Group 
Age in months at 
time of study 
Mean (SD) range 
Time (months) 
since diagnosis 
Mean (SD) range Gender 
VABS Percentile 
Mean (SD) range 
6 years or less 
N=8 
44.1 (23.2) 21-81 26.1 (22.2) 6-67  5 females, 3 males 13.7 (7.3) 4-21  
7 years or older 
N=8 
141.6(20.8)105-168 119.6 (29.4)63-147 8 females 13.3 (31.0)1-5(90a) 
Total n=16 92.8 (54.7) 21-168 72.9 (54.5) 6-147 13 females,3 males 13.4 (23.2) 1-90 
a One outlier with a percentile score of 90; Abbreviation: VABS, Vineland Adaptive Behaviour Scale 
  
  
 
 
Table 2. Presentation of Behavior and Sensory Profile  by presence of Anxiety 
Group (n) 
Age months 
Mean (SD)  
range 
Time (months) 
since diagnosis 
Mean (SD) range 
VABS Percentile 
Mean (SD)  
rangea 
SSP Total score 
Mean (median)  
range  
No Anxiety (8) 81.5 (54.8)  
21-146 
61.0 (55.0)  
6-133 
21.9 (31.1)  
2-90  
162.6 (164.5)  
133-184 
Anxiety (8) 104.3 (55.7)  
31-168 
84.8 (54.9)  
11-147 
5.0 (6.0)  
1-18 
132.7 (137.5)  
89-174 
Total (16) 92.88 (54.7)  
21-168 
72.9 (54.5)  
6-147 
13.4 (23.2)  
1-90 
147.6 (149.5)  
89-184 
a n = 7 per group; Abbreviations: VABS,Vineland Adaptive Behavior Scale; SSP,Short Sensory Profile 
 
 
